⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRLD News
Prelude Therapeutics Incorporated
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
globenewswire.com
PRLD
Form 8-K
sec.gov
PRLD
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
globenewswire.com
PRLD
Form 8-K
sec.gov
PRLD
Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
PRLD
PreludeDx Announces Collaboration with Learn Look Locate to Expand Patient Education Around DCIS Treatment Decisions
prnewswire.com
PRLD
Form 8-K
sec.gov
PRLD
Form 8-K
sec.gov
PRLD
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
PRLD
PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® - Early-Stage Invasive Breast Cancer Assay
prnewswire.com
PRLD